STOCK TITAN

Enovis (ENOV) former EVP reports stock sales, still holds 160,449 shares

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Enovis Corp insider, a former Executive Vice President of Strategy & Business Development, reported multiple stock sales in a Form 4 filing. On December 9, 2025, the reporting person sold 666 shares of Enovis common stock at $27.21 per share in a direct transaction and held 160,449 shares directly afterward, plus 932 shares through a 401(k) plan. On the same date, three separate sales of 333 shares each were made at prices around $27.20 per share through trusts for the reporting person's daughter and son, leaving those trusts with no remaining shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PRYOR DANIEL A

(Last) (First) (Middle)
2711 CENTERVILLE ROAD
SUITE 400

(Street)
WILMINGTON DE 19808

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Former EVP, Strategy & Bus Dev
3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 12/09/2025 S 666 D $27.21 160,449 D
Common stock, par value $0.001 12/09/2025 S 333 D $27.21 0 I By trust for daughter
Common stock, par value $0.001 12/09/2025 S 333 D $27.18 0 I By trust for daughter
Common stock, par value $0.001 12/09/2025 S 333 D $27.22 0 I By trust for son
Common stock, par value $0.001 932 I By 401k plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Brian P. Hanigan, attorney-in-fact 12/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovis (ENOV) disclose in this Form 4?

The filing reports that a former Enovis EVP, Strategy & Business Development sold Enovis common stock in several transactions on December 9, 2025.

How many Enovis (ENOV) shares did the insider sell directly?

The reporting person sold 666 shares of Enovis common stock in a direct transaction at a price of $27.21 per share.

What were the Enovis (ENOV) trust transactions mentioned in the Form 4?

Three sales of 333 shares of Enovis common stock each were made on December 9, 2025 through trusts for the reporting person's daughter and son at prices around $27.20 per share, leaving those trusts with no shares.

How many Enovis (ENOV) shares does the insider still own after these sales?

After the reported transactions, the insider held 160,449 shares of Enovis common stock directly and 932 shares indirectly through a 401(k) plan.

What is the relationship of the reporting person to Enovis (ENOV)?

The reporting person is identified as a former EVP, Strategy & Bus Dev of Enovis and is filing the Form 4 as one reporting person.

At what prices were the Enovis (ENOV) shares sold in the reported transactions?

The direct sale occurred at $27.21 per share, while the trust sales were reported at $27.21, $27.18, and $27.22 per share.
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.45B
56.23M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON